BioSpace News Archive

TipRanks, the world’s leading analyst ranking service, has identified the Top 10 Wall Street analysts of 2018.

The Board of Directors of GEHA has announced that following a nationwide search Darren Taylor has been selected as President and Chief Executive Officer

The FDA’s focus on both safety and innovation stems from our historic mission to protect and promote public health—to assure that medical devices on the U.S. market are high-quality, safe and effective and to facilitate innovation and assure that patients and providers have timely and continued access to these high-quality, safe and effective devices.

Optibrium™, a developer of software for drug discovery, today announced the appointment of Clare Devlin as Financial Director.

Microbiotica, a leading player in microbiome-based therapeutics, is pleased to confirm upcoming conference activity for the first quarter of 2019.

According to a recent study conducted by RRI, the global market for neuropathic pain is expected to reflect a CAGR of over 5% during the forecast period (2016–2024).

Wolters Kluwer Legal & Regulatory U.S. today announced that registration is open for its 2019 three-part webinar series to help healthcare professionals understand the complex questions and legal issues surrounding consent to treatment.

Tivity Health®, Inc. (NASDAQ:TVTY) today announced preliminary unaudited financial results for the quarter and year ended December 31, 2018.

Pulmatrix, Inc. (“Pulmatrix,” the “Company,” “we,” “our” or “us”) (NASDAQ: PULM) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its board of directors has appointed Robert Yates as chairman and chief executive officer effective February 12, 2019. R